Clinical trial

Early Diagnosis of Breast Cancer-related Lymphedema

NCT06046365

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention lymphoscintigraphy Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention circumference measurement Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention sonography Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention DXA body composition analysis Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Early Diagnosis of Breast Cancer-related Lymphedema

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2022-10-24

PhaseN/A

Conditions

Lymphedemaverified · MONDO: lymphedema

Interventions

lymphoscintigraphyDIAGNOSTIC_TEST

circumference measurementDIAGNOSTIC_TEST

sonographyDIAGNOSTIC_TEST

DXA body composition analysisDIAGNOSTIC_TEST

Sponsors & collaborators

Kaohsiung Veterans General Hospital.lead sponsor

Mapped research locations

Kaohsiung CityTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06046365 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.